Gregory G. Burrows - Concepedia

Author

Gregory G. Burrows

Oregon Health & Science University

Also Known As

Burrows, G.G., G G Burrows, G.G. Burrows, Gregory Burrows, Gregory G Burrows, Gregory G. Burrows, Gregory G. Burrows

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University Portland VA Medical Center Veterans Health Administration Neurology, Inc Institute of Neuroimmunology of the Slovak Academy of Sciences

About

Gregory G. Burrows is an author at Oregon Health & Science University specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	739
2	Cell Biology	11	11	354
3	Allergy	7	7	197
4	Natural Sciences	3	3	158
5	Biochemistry	1	1	92

Gregory G. Burrows

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Decreased FOXP3 levels in multiple sclerosis patients Jianya Huan, Nicole Culbertson, Leslie Spencer, Journal of Neuroscience Research	2005	365
Deducing the organization of a transmembrane domain by disulfide cross-linking. The bacterial chemoreceptor Trg. G F Lee, Gregory G. Burrows, Michael Lebert, Journal of Biological Chemistry Cysteine PairsBacterial Chemoreceptor TrgProtein SecretionProteinlipid InteractionProtein Assembly	1994	92
Recombinant TCR Ligand Induces Tolerance to Myelin Oligodendrocyte Glycoprotein 35-55 Peptide and Reverses Clinical and Histological Signs of Chronic Experimental Autoimmune Encephalomyelitis in HLA-DR2 Transgenic Mice Arthur A. Vandenbark, Cathleen Rich, Jeff Mooney, The Journal of Immunology ImmunologyImmune RegulationImmunologic MechanismImmunotherapyImmune Dysregulation	2003	87
Recombinant T Cell Receptor Ligand Treats Experimental Stroke Sandhya Subramanian, Bing Zhang, Yasuharu Kosaka, Stroke	2009	78
Myelin oligodendrocyte glycoprotein‐35–55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA‐DR2‐transgenic mice Cathleen Rich, Jason M. Link, Alex Zamora, European Journal of Immunology Immune RegulationImmunologyPathologyAntigen ProcessingImmunotherapy	2004	60
Design, engineering and production of functional single-chain T cell receptor ligands Gregory G. Burrows, Jinjie Chang, H-P. Bächinger, Protein Engineering Design and Selection	1999	60
A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS Sushmita Sinha, Sandhya Subramanian, Thomas M. Proctor, Journal of Neuroscience	2007	54
Partial <scp>MHC</scp> class <scp>II</scp> constructs inhibit <scp>MIF</scp>/<scp>CD</scp>74 binding and downstream effects Gil Benedek, Roberto Meza‐Romero, Shayne F. Andrew, European Journal of Immunology Immune RegulationImmunologyMolecular BiologyImmunologic MechanismAntigen Processing	2013	53
HLA-DRα1 Constructs Block CD74 Expression and MIF Effects in Experimental Autoimmune Encephalomyelitis Roberto Meza‐Romero, Gil Benedek, Xiaolin Yu, The Journal of Immunology	2014	53
Monomeric Recombinant TCR Ligand Reduces Relapse Rate and Severity of Experimental Autoimmune Encephalomyelitis in SJL/J Mice through Cytokine Switch Jianya Huan, Sandhya Subramanian, Richard E. Jones, The Journal of Immunology	2004	51

Page 1